| |
| Issue |
Title |
| |
| No 21 (2024) |
A clinical case of the effectiveness of the anti PD-1 inhibitor (prolgolimab) in the treatment of metastatic melanoma |
Abstract
PDF (Rus)
|
|
P. V. Golubev, T. I. Deshkina, L. V. Bolotina, E. S. Kuzmina, S. A. Golubeva, I. A. Pokataev, V. N. Galkin |
| |
| No 21 (2024) |
Non-small cell lung cancer with MET mutation: a clinical case of treatment with MET inhibitor capmatinib |
Abstract
PDF (Rus)
|
|
K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, V. S. Chalov, I. A. Menshikova, A. F. Nasretdinov, N. I. Sultanbaeva, Sh. N. Galimov |
| |
| No 22 (2023) |
The role of durvalumab in the treatment of biliary tract tumors |
Abstract
PDF (Rus)
|
|
E. V. Ledin, V. I. Stolyarov |
| |
| No 22 (2023) |
Сlinical case of visceral metastasis of cutaneous melanoma |
Abstract
PDF (Rus)
|
|
A. V. Solovieva, O. M. Uryasev, O. V. Kodyakova, M. S. Bolotina, I. V. Vasin, E. M. Shurpo |
| |
| No 22 (2023) |
Signet ring-cell colorectal adenocarcinoma: review and clinical case |
Abstract
PDF (Rus)
|
|
S. S. Yashin, Yu. R. Yunusova, K. K. Noskov, A. S. Ivanyukov |
| |
| No 22 (2023) |
Long-term preservation of the effect of immunotherapy with pembrolizumab as a second line treatment for recurrent skin melanoma |
Abstract
PDF (Rus)
|
|
L. M. Kogoniya, E. V. Markarova |
| |
| No 7 (2023) |
The experience of using sodium aminodihydrophthalazinedione in the complex treatment of a patient with Ramsey – Hunt syndrome |
Abstract
PDF (Rus)
|
|
M. A. Shakhova, A. B. Terentyeva |
| |
| No 7 (2023) |
Complex therapy for prolonged cough in infectious and inflammatory diseases of the upper respiratory tract: case report |
Abstract
PDF (Rus)
|
|
S. V. Morozova, E. B. Moskvitina, T. Kh. Shadyev, E. A. Dyadishcheva |
| |
| No 22 (2022) |
PIK3CA-mutated breast cancer: from research to clinical practice |
Abstract
PDF (Rus)
|
|
A. L. Kornietskaya, L. V. Bolotina, S. F. Evdokimova, V. V. Savchina, Yu. B. Karagodina, A. A. Kachmazov |
| |
| No 22 (2022) |
Clinical case of long-term disease control in a patient with EGFR-positive non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
V. A. Kuzmina, K. K. Laktionov, E. V. Reutova, M. A. Ardzinba, E. S. Denisova |
| |
| No 20 (2022) |
On the issue of effective engraftment of tissues in the plastic of the tympanic membrane |
Abstract
PDF (Rus)
|
|
V. S. Isachenko, V. V. Dvoryanchikov, D. M. Ilyasov, S. Yu. Ognetov, K. I. Sotnikova |
| |
| No 9 (2022) |
Nivolumab with Ipilimumab in the treatment of refractory hepatocellular carcinoma |
Abstract
PDF (Rus)
|
|
M. N. Khagazheeva, I. A. Dzhanyan, V. V. Breder, K. K. Laktionov |
| |
| No 9 (2022) |
Ribociclib in patient with hormone-positive HER2-negative breast cancer with brain metastases: a case report |
Abstract
PDF (Rus)
|
|
N. S. Prizova, L. V. Bolotina, A. L. Kornietskaya |
| |
| No 9 (2022) |
Long-term disease control in a patient with ALK-positive non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
G. I. Berezina, K. K. Laktionov, E. V. Reutova, M. S. Ardzinba, T. N. Borisova, V. L. Utkina |
| |
| No 9 (2022) |
Experience with olaparib in a patient with luminal HER2-positive metastatic breast cancer |
Abstract
PDF (Rus)
|
|
L. V. Bolotina, A. L. Kornietskaya, A. A. Kachmazov, N. S. Prizova, A. A. Paichadze, T. V. Ustinova, T. I. Deshkina, S. F. Evdokimova |
| |
| No 9 (2022) |
Checkpoint inhibitors in non-small cell lung carcinoma therapy for progression to the brain (clinical observation) |
Abstract
PDF (Rus)
|
|
L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, A. A. Lianova, A. E. Storozhakova, L. A. Ryadinskaya, S. N. Kabanov, E. A. Kalabanova |
| |
| No 9 (2022) |
Experience in correcting skin radiation reactions with basic care products. Clinical observation |
Abstract
PDF (Rus)
|
|
A. R. Akhtemzyanov, S. M. Pinyaeva, E. N. Nikolaeva, T. E. Emileva |
| |
| No 9 (2022) |
Therapy options for metastatic triple negative breast cancer |
Abstract
PDF (Rus)
|
|
E. V. Glazkova, M. A. Frolova, E. R. Israelyan |
| |
| No 9 (2021) |
Case report of partial response on second line with Ramucirumab and FOLFIRI in treatment of 74 year old male with metastatic HER2-negative gastric adenocarcinoma |
Abstract
PDF (Rus)
|
|
N. S. Besova, T. A. Titova, A. E. Kalinin, V. A. Shalenkov, I. S. Stilidi |
| |
| No 9 (2021) |
Mechanisms of metastasis and development of resistance to therapy in breast cancer. A clinical case of the effectiveness of ixabepilone in hormone-receptorpositive breast cancer with multidrug resistance |
Abstract
PDF (Rus)
|
|
A. I. Stukan, A. Y. Goryainova, S. V. Sharov, D. V. Andreev, E. V. Lymar |
| |
| No 9 (2021) |
Clinical case of the use of oral metronomic vinorelbin in patient with metastatic Her2 negative breast cancer |
Abstract
PDF (Rus)
|
|
M. A. Frolova, E. V. Glazkova, M. B. Stenina |
| |
| No 9 (2021) |
Experience of treatment of a patient with non-small cell lung cancer with met exon 14 skipping |
Abstract
PDF (Rus)
|
|
M. O. Mandrina, V. V. Breder, M. V. Ivanov, A. A. Lebedeva, V. V. Gorbatsevich, K. K. Laktionov, P. V. Kononets |
| |
| No 4S (2021) |
A clinical case of treatment of a patient with acute adrenal insufficiency after combined immunotherapy (nivolumab + ipilimumab). Prospects for a return to immunotherapy after severe complications of immunotherapy |
Abstract
PDF (Rus)
|
|
К. К. Laktionov, К. А. Sarantseva, D. I. Yudin, М. F. Beloyartseva, G. S. Yunaev |
| |
| No 4S (2021) |
Lynch syndrome as a manifestation of hereditary ovarian cancer: a case report of treatment of a patient with platinum-sensitive recurrent ovarian cancer |
Abstract
PDF (Rus)
|
|
R. R. Faiskhanova, D. D. Sakaeva |
| |
| No 4S (2021) |
Alpelisib as a new treatment option for patients with the PIK3CA mutation. The effectiveness and tolerability of therapy on the example of a clinical case |
Abstract
PDF (Rus)
|
|
Е. I. Kovalenko, Е. V. Artamonova |
| |
| No 20 (2020) |
Experience of targeted therapy for ALK positive non-small cell lung cancer – a clinical case |
Abstract
PDF (Rus)
|
|
A. V. Sultanbaev, Sh. I. Musin, K. V. Menshikov, A. F. Nasretdinov, B. A. Ibragimov, A. G. Nigmatullin, R. T. Ayupov, A. A. Izmailov, N. I. Sultanbaeva |
| |
| No 20 (2020) |
Abscopal effect in a patient with metastatic NSCLC following a course of radiation therapy to the brain |
Abstract
PDF (Rus)
|
|
E. S. Denisova, K. K. Laktionov, T. N. Borisova, Merab. S. Ardzinba, A. A. Fedorova, D. I. Yudin, S. S. Magamedova, Milada A. Ardzinba |
| |
| No 20 (2020) |
Clinical case of use of osimertinib in a patient with disseminated EGFR-mutated non-small cell lung cancer in the first-line therapy |
Abstract
PDF (Rus)
|
|
K. A. Sarantseva, K. K. Laktionov, E. V. Reutova, D. I. Yudin, V. V. Breder |
| |
| No 20 (2020) |
A case of effective disease control of advanced gastric cancer following ramucirumab plus FOLFIRI in second line treatment in clinical practice |
Abstract
PDF (Rus)
|
|
T. A. Titova, N. S. Besova, E. A. Artamonova |
| |
| No 20 (2020) |
Combination of chemoradiation therapy with immunotherapy in the treatment of patients with inoperable stage III non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
N. V. Marinichenko, K. K. Laktionov, A. V. Nazarenko, E. V. Reutova, Merab S. Ardzinba, V. L. Utkina, T. N. Borisova, A. A. Fedorova, Milada S. Ardzinba |
| |
| No 20 (2020) |
Trastuzumab emtansine of the treatment of HER2-positive breast cancer with brain metatases |
Abstract
PDF (Rus)
|
|
L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. Lyanova, L. A. Ryadinskaya, M. O. Ezhova, V. S. Myagkova, L. K. Strakhova |
| |
| No 9 (2020) |
Clinical case of long-term use of atezolizumab and bevacizumab in the first-line treatment of recurrence of non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
O. A. Rozonova, I. Y. Bazaeva, V. A. Gorbunova, E. V. Artamonova |
| |
| No 9 (2020) |
Primary multiple BRCA associated breast cancer and ovarian cancer (clinical case) |
Abstract
PDF (Rus)
|
|
I. B. Kononenko, A. V. Snegovoy, Y. A. Bozhchenko, D. N. Kravchenko, Vladimir Yu. Selchuk, O. V. Palchinskaia |
| |
| No 9 (2020) |
A case report of immune-related pneumonitis after combined treatment of non small cell lung cancer |
Abstract
PDF (Rus)
|
|
E. S. Denisova, M. S. Ardzinba, K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, G. V. Shcherbakova, N. V. Marinichenko |
| |
| No 9 (2020) |
The possibilities of using xenon therapy in patients with severe cancer pain |
Abstract
PDF (Rus)
|
|
R. R. Sarmanayeva, G. R. Abuzarova, N. M. Bychkova, V. E. Khoronenko, S. V. Kuznetcov |
| |
| No 9 (2020) |
Conservative treatment of stage III lung cancer using chemoradiotherapy in hypofractionation mode, case report |
Abstract
PDF (Rus)
|
|
N. V. Marinichenko, K. K. Laktionov, A. V. Nazarenko, T. N. Borisova, M. S. Ardzinba, A. A. Fedorova, P. V. Murashova, M. S. Ardzinba |
| |
| No 9 (2020) |
Experience of long-term clinical observation of a patient with a rare type of stomach cancer – lymphoepithelioma-like carcinoma |
Abstract
PDF (Rus)
|
|
L. M. Kogoniya, L. E. Gurevich, V. S. Mazurin, E. V. Markarova |
| |
| No 9 (2020) |
Thyroid cancer: retrospective study of patients with surgical treatment (a single-center experience) |
Abstract
PDF (Rus)
|
|
M. O. Rogova, N. S. Martirosian, L. V. Trukhina, N. B. Paramonova, K. E. Slobodin, L. I. Ippolitov, N. A. Petunina |
| |
| No 2 (2020) |
Ischemic stroke on the background of probable in situ thrombosis of atrial septal aneurysm in a patient taking hormonal contraceptives |
Abstract
PDF (Rus)
|
|
S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova |
| |
| No 19 (2019) |
Clinical example of long-term control of disseminated signet-ring cell carcinoma of the stomach against the background of chemotherapy of the second line of treatment in combination with bevacizumab |
Abstract
PDF (Rus)
|
|
T. A. Titova, N. S. Besova, E. V. Artamonova |
| |
| No 19 (2019) |
Immunotherapy in first-line treatment of recurrent non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
E. O. Rodionov, S. V. Miller, S. A. Tuzikov, L. A. Efteev, V. A. Markovich, D. S. Miller |
| |
| No 19 (2019) |
Sunitinib in pancreatic neuroendocrine tumors. Clinical case |
Abstract
PDF (Rus)
|
|
A. A. Markovich, A. A. Kuznetsova, E. L. Dronova, G. S. Emel’yanova |
| |
| No 19 (2019) |
Clinical case of prolonged use of alectinib in the treatment of ALK-positive NSCLC |
Abstract
PDF (Rus)
|
|
S. G. Bagrova, A. A. Kolomeytseva, E. V. Trusilova, V. A. Gorbunova |
| |
| No 19 (2019) |
Possibilities of therapeutic use of HER2-inhibitorsin metastatic colorectal cancer: a case report |
Abstract
PDF (Rus)
|
|
A. A. Kachmazov, L. V. Bolotina, A. L. Kornietskaya, T. V. Ustinova, V. A. Tolstov, A. A. Fedenko |
| |
| No 13 (2019) |
Hormonal assessment of patients of reproductive age with uterine myoma for surgical treatment |
Abstract
PDF (Rus)
|
|
A. V. Kozachenko, Z. V. Revazova, L. V. Adamyan, T. A. Demura, N. V. Zaytsev |
| |
| No 10 (2019) |
Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinoma |
Abstract
PDF (Rus)
|
|
L. M. Kogonia, E. V. Markarova, G. A. Stashuk, M. M. Byakhova, M. M. Akhmetov |
| |
| No 10 (2019) |
Systemic control of cerebral metastases in a patient with HER2-positive metastatic breast cancer. Clinical case |
Abstract
PDF (Rus)
|
|
S. F. Menshikova, M. A. Frolova, M. B. Stenina |
| |
| No 10 (2019) |
Clinical example of enhancing efficacy of paclitaxel by combining it with ramuchirumabin in the second-line chemotherapy of disseminated gastric cancer |
Abstract
PDF (Rus)
|
|
T. A. Titova, E. V. Artamonova, N. S. Besova |
| |
| No 7 (2019) |
Non-surgical treatment of uterine fibroids. Efficacy of the selective progesterone receptor modulator |
Abstract
PDF (Rus)
|
|
E. R. Dovletkhanova, E. A. Mezhevitinova, V. N. Prilepskaya |
| |
| No 7 (2019) |
Prevention of recurrent endometrial pathology |
Abstract
PDF (Rus)
|
|
A. L. Tikhomirov, S. I. Sarsania, K. S. Tuskayev, T. A. Yudina |
| |
| No 7 (2019) |
Nonsteroidal anti-inflammatory drugs for management of pelvic pain in women |
Abstract
PDF (Rus)
|
|
I. V. Kuznetsova, L. V. Evsyukova |
| |
| No 19 (2018) |
Phenotypic transformation as a cause of secondary drug resistance to osimetinib clinical observation |
Abstract
PDF (Rus)
|
|
L. A. Nelyubina, E. V. Reutova, K. K. Laktionov, D. I. Yudin, D. T. Marinov, E. N. Kozak, V. V. Mochalnikova |
| |
| No 13 (2018) |
Clinical observation: giant uterine myoma. The tactic of surgical treatment and postoperative management |
Abstract
PDF (Rus)
|
|
N. A. Buralkina, G. A. Vlasov, A. V. Veredchenko, V. V. Chursin, A. V. Asaturova, E. P. Fedotkina, E. A. Kalabukhova, V. D. Chuprykin |
| |
| No 13 (2018) |
Prevention of fetal growth restriction in placental insufficiency |
Abstract
PDF (Rus)
|
|
Z. V. Khachatryan, N. A. Lomova, A. A. Khachatryan, V. L. Tyutyunnik, N. E. Kan |
| |
| No 10 (2018) |
Palbociclib in the first line combination hormone therapy of HER2- negative metastatic hormone-dependent breast cancer. Clinical follow-up |
Abstract
PDF (Rus)
|
|
M. A. Frolova, E. B. Glazkova, M. B. Stenina |
| |
| No 10 (2018) |
«Renal masks» of acute leucosis in children |
Abstract
PDF (Rus)
|
|
A. Ni, T. A. Shumatova, E. V. Sergeeva, N. G. Prikhodchenko, E. S. Zernova, S. N. Shishatskaya, E. Yu. Katenkova, L. A. Grigoryan, I. Chun En, A. V. Kapelyukh |
| |
| No 10 (2018) |
Case report of the rapid achievement of sustained and long-term remission resulting from the use of ramucirumab plus paclitaxel in the second-line treatment of a patient with disseminated gastric adenocarcinoma |
Abstract
PDF (Rus)
|
|
T. A. Titova, N. S. Besova, V. A. Gorbunova, Yu. P. Kuvshinov, A. A. Filatov, A. F. Ketsba, A. A. Fedenko |
| |
| No 7 (2018) |
Dysmenorrhea: pathogenetic validation of pharmacotherapy |
Abstract
PDF (Rus)
|
|
N. A. Buralkina, A. S. Katkova, I. A. Kiseleva |
| |
| No 13 (2017) |
ANTITHROMBOTIC PREVENTION IN WOMEN WITH MEDICAL HISTORY SIGNIFICANT FOR OBSTETRIC AND THROMBOTIC EVENTS. CLINICAL OBSERVATION |
Abstract
PDF (Rus)
|
|
D. K. Khizroeva |
| |
| 1 - 59 of 59 Items |
|
